BioSpace News Archive

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that it will report results for the second quarter ended June 30, 2020 and provide a business update after market close on Tuesday, August 4, 2020. Management will host a conference call for investors at 8:00 a.m. ET on Wednesday

PGP, (The Public Good Projects), a public health nonprofit responsible for some of the nation’s most successful health campaigns, announces today the launch of STRONGER, a first-of-its-kind national advocacy campaign against misinformation and for vaccines.

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today provided an update on the manufacturing strategy for Berubicin drug product, its lead drug candidate for the tre

AstraZeneca, a longtime supporter of the mission of the American Cancer Society (ACS), continues a legacy of commitment in the fight against cancer with a $489,000 contribution.

Proceeds will advance CAB-AXL and CAB-ROR2 clinical programs into Phase 2 trials, CAB-CTLA-4 Phase 1 trial, and additional CAB development programs

With many countries facing shortages of personal protective equipment (PPE), one of Israel’s leading manufacturers is offering to share its production expertise and provide emergency supplies

CVS Health announced the official launch of Time for Care, a campaign that reinforces the importance of accessing primary health care.

Makes AQC model, designed to improve quality and lower costs, available to smaller practices Also offers immediate support payment to practices that adopt model [15-July-2020] BOSTON , July 15, 2020 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) is launching an innovative program to improve the quality of patient care, slow the rise o

Smiths Medical, a leading global medical device manufacturer, announced today a strategic public-private partnership with Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness and Response,

DiaCarta Receives Regulatory COFEPRIS Approval in Mexico & ICMR Approval in India for its FDA EUA Approved QuantiVirus ™ SARS-CoV-2 Test